A 2024 “Unity Ticket” & the Road Ahead for Weight Loss Drugs 01/02/24

Squawk Pod

CNBC

Business News, News, Investing, Business

4.2 • 543 Ratings

🗓️ 2 January 2024

⏱️ 29 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

2024 trading begins after a strong market finish to 2023, with the Nasdaq 100 closing its best year since 1999. Just over 300 days before the 2024 election, former Connecticut Senator Joe Lieberman is pushing for an option outside of President Biden and President Trump. Once on the Presidential ticket himself, Lieberman started nonprofit No Labels, which hopes to offer a third, bipartisan, centrist “unity ticket” to the Americans unsatisfied with the current political playing field. Plus 2023 was the year of weight loss drugs for pharma companies like Novo Nordisk and Eli Lilly. Former FDA Commissioner Dr. Scott Gottlieb sits on the boards of Illumina and Pfizer, and he expects more good news–and more secondary benefits–from weight loss drugs on the market. Plus, Michigan is celebrating a big sports weekend, and X is now worth 71.5% less than when Elon Musk bought it, according to Fidelity, one of the co-investors that backed his takeover. Joe Lieberman - 12:30 Dr. Scott Gottlieb - 24:46 In this episode: Scott Gottlieb, @ScottGottliebMD Becky Quick, @BeckyQuick Robert Frank, @robtfrank Michael Santoli, @michaelsantoli Katie Kramer, @Kramer_Katie

Transcript

Click on a timestamp to play from that location

0:00.0	Bring in show music please.
0:03.0	Hi, I'm C. NBC producer Katie Kramer.
0:07.0	Today on Squack Pod.
0:09.0	The first trading day of 2024, what a year we're following up.
0:13.6	For the NASDAQ 100, what was this the best year since 1999?
0:18.1	And what comes in 24? An election.
0:20.7	Former Senator Joe Lieberman is hoping to give Americans a third choice, what he's called a unity ticket.
0:26.0	I think the American people are really yearning for almost demanding a third choice.
0:31.0	They're fed up with the two major parties.
0:33.0	Why he thinks he's got a good shot at turning Washington's tables.
0:37.0	Almost half the people in our country today, if you ask them, say their independence.
0:43.8	Pharma Giants, Novo Nordisk, and Eli Lilly's weight lost drugs
0:47.1	stole the headlines in 2023.
0:49.2	Former FDA Commissioner Scott Gottlieb says
0:51.7	there could be more than shedding pounds to
0:53.6	look forward to. Combined both companies have about 15 trials underway looking at
0:57.9	secondary benefits of these drugs in diseases that are associated with weight
1:02.4	gain.
1:03.0	Those stories plus a big weekend for Michigan Wolverines
1:07.0	and X's valuation marked down by over 70%.
1:11.0	What now?
1:12.0	Would Twitter have somehow convinced the market that it was an AI play?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.